Trials / Completed
CompletedNCT04651023
Shanghai Meiji Health Science and Technology Co., Ltd
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 95 (actual)
- Sponsor
- Shanghai Meiji Health Science and Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
Investigators performed a randomized double-blind trial to determine the effects of long-term NnEx ingestion in patients with overweight or obesity. Ninety-five participants (23\<BMI\<30 kg/m2) were randomly allocated to three groups: a control group, a 1 g/day NnEx group, and a 2 g/day NnEx group. The effects of the consumption of 2 g/day or 1 g/day NnEx for 12 weeks on indices of adiposity and fasting blood metabolic parameters were compared with those of no consumption of NnEx.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Nelumbo nucifera Leaf Extract | Hot water extracted Nelumbo nucifera Leaf, mainly containing quercetin and quercetin 3-O-glucuronide. |
Timeline
- Start date
- 2009-01-10
- Primary completion
- 2009-05-15
- Completion
- 2009-06-20
- First posted
- 2020-12-03
- Last updated
- 2020-12-03
Source: ClinicalTrials.gov record NCT04651023. Inclusion in this directory is not an endorsement.